Vifor Pharma AG Logo

Vifor Pharma AG

VIFN | SW

Overview

Corporate Details

ISIN(s):
CH0364749348
LEI:
529900KO6CN2D9OE1F19
Country:
Switzerland
Address:
Rechenstrasse 37, 9014 St. Gallen
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

CSL Vifor is a global specialty biotechnology company focused on iron deficiency, nephrology, and rare diseases. A pioneer and global leader in iron-based therapies, the company develops, manufactures, and markets pharmaceutical products to address significant unmet medical needs. Its core therapeutic areas include iron deficiency anemia in conditions such as heart failure, kidney disease, gastroenterology, and women's health. In partnership with its joint company, Vifor Fresenius Medical Care Renal Pharma, CSL Vifor has a strong and growing presence in treating the full spectrum of kidney disease. The company's business model emphasizes strategic global partnering, in-licensing, and commercializing innovative therapies, with a presence in over 100 countries.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Vifor Pharma AG. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Vifor Pharma AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Vifor Pharma AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2022-03-09 N/A Executive member Sell None 4,335,210.00 CHF
2022-03-09 N/A Non-Executive member Sell None 1,951,125.00 CHF
2022-03-09 N/A Non-Executive member Sell None 1,851,300.00 CHF
2022-03-09 N/A Executive member Sell None 1,535,160.00 CHF
2022-03-09 N/A Non-Executive member Sell None 1,450,515.00 CHF
2022-03-09 N/A Executive member Sell None 920,205.00 CHF
2022-03-09 N/A Executive member Sell None 530,310.00 CHF
2022-03-09 N/A Non-Executive member Sell None 382,140.00 CHF
2022-03-09 N/A Non-Executive member Sell None 330,495.00 CHF
2022-03-09 N/A Executive member Sell None 287,925.00 CHF

Peer Companies

Company Country Ticker View
Teva Pharmaceutical Industries Ltd. Logo
A global leader in generic drugs and innovative medicines for CNS and immuno-oncology.
Israel TEVA
TheraVet SA Logo Belgium ALVET
Thor Medical ASA Logo
Sustainably produces alpha-emitters from thorium for cancer therapies, without nuclear reactors.
Norway NANOV
Tikun Olam Cannbit Pharmaceuticals Ltd. Logo
Vertically integrated R&D and production of clinically-validated medical cannabis treatments.
Israel TKUN
TMS Co., Ltd Logo Japan 4891
Together Pharma Ltd. Logo
Researches and produces medical cannabis products for domestic and European patients.
Israel TGTR
Japan 4551
TOWA PHARMACEUTICAL CO.,LTD. Logo Japan 4553
TSUMURA & CO. Logo Japan 4540
TURK İLAÇ VE SERUM SANAYİ A.Ş. Logo
Turkish pharma producer of human medicines, vaccines, and high-capacity IV solutions (serum).
Türkiye TRILC